Cite
Tumor-draining lymph node-derived tumor-specific memory CD8+ T cells: a key player in PD-1/PD-L1 immunotherapy.
MLA
Yin, Enzhi, et al. “Tumor-Draining Lymph Node-Derived Tumor-Specific Memory CD8+ T Cells: A Key Player in PD-1/PD-L1 Immunotherapy.” Signal Transduction & Targeted Therapy, vol. 8, no. 1, Mar. 2023, pp. 1–3. EBSCOhost, https://doi.org/10.1038/s41392-023-01356-0.
APA
Yin, E., Sun, N., & He, J. (2023). Tumor-draining lymph node-derived tumor-specific memory CD8+ T cells: a key player in PD-1/PD-L1 immunotherapy. Signal Transduction & Targeted Therapy, 8(1), 1–3. https://doi.org/10.1038/s41392-023-01356-0
Chicago
Yin, Enzhi, Nan Sun, and Jie He. 2023. “Tumor-Draining Lymph Node-Derived Tumor-Specific Memory CD8+ T Cells: A Key Player in PD-1/PD-L1 Immunotherapy.” Signal Transduction & Targeted Therapy 8 (1): 1–3. doi:10.1038/s41392-023-01356-0.